The diagnosis of Classic FMS fits the patient who has a significant sleep disorder, brain injury, depression, anxiety syndrome, and/or some other type of central nervous system dysfunction that leads to abnormal processing of sensory stimuli
Studies have shown that GLP-1 agonists can trigger effects in the brain, the heart, the liver, the pancreas, the stomach, and the musclesmeaning that they could have implications for conditions other than type 2 diabetes and obesity, such as heart disease, kidney disease, liver disease, and even neurological conditions such as Alzheimer's disease
The Cancelled Phase I Trial The most significant missed opportunity in BPC-157 research occurred in 2015-2016
& Lefcort, F
When to Be Extra Cautious With Fertility Supplements